These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9494546)

  • 1. Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models.
    Imam SA; Kim MS; Anker L; Datar RH; Law RE; Taylor CR
    Anticancer Res; 1997; 17(6D):4435-41. PubMed ID: 9494546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization.
    Sun W; Kang KS; Morita I; Trosko JE; Chang CC
    Cancer Res; 1999 Dec; 59(24):6118-23. PubMed ID: 10626801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines.
    Pilat MJ; Schwab ED; Yao KL; Pienta KJ
    Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines.
    Stampfer MR; Garbe J; Nijjar T; Wigington D; Swisshelm K; Yaswen P
    Oncogene; 2003 Aug; 22(34):5238-51. PubMed ID: 12917625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.
    Garbe J; Wong M; Wigington D; Yaswen P; Stampfer MR
    Oncogene; 1999 Apr; 18(13):2169-80. PubMed ID: 10327063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
    Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in normal and neoplastic breast.
    Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
    Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
    Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
    Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC
    Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
    Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
    J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier.
    Lewis CM; Herbert BS; Bu D; Halloway S; Beck A; Shadeo A; Zhang C; Ashfaq R; Shay JW; Euhus DM
    Breast Cancer Res Treat; 2006 Sep; 99(1):103-15. PubMed ID: 16541310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in ovarian tumors.
    Murakami J; Nagai N; Ohama K; Tahara H; Ide T
    Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.